Nabros Pharma is a leading global pharmaceutical formulation development, manufacturing and marketing company headquartered in India, incorporated in 1983. Under strong leadership of founder and CEO Shree Navneet Shah, Nabros Pharma has working and growing tremendously from last three and half decades.
Nabros Pharma is the 1st manufacturer of Phospholipids in India.
Nabros Pharma is having presence in various formulation segments like Cardiovascular system (CVS), Diabetology, Respiratory care, Gastroenterology, Pain management as well as other therapeutic segments. Some of our brands like Essliver Forte Cap., Cartil Super Forte Cap., Dolaren Tab., Flucold Tab., Nabros Heel Cream, Sanalex Tab., Kofanol Tab., etc. are market leaders in various countries.
Nabros Pharma has strong presence in CIS, Central & Latin America, Africa and Asia. Nabros Pharma is also having global strategic alliances with leading Global Pharmaceutical Companies for development and distribution of products.
Nabros Energy is a research-based company in the energy sector. Nabros Energy is mainly working in research and development of 5 fields like Hydrothermal Liquefaction, Power generation through Supercritical Carbon Dioxide, Chemical extraction, Supercritical Carbon Dioxide Extraction and Isothermal Compression.
Nabros Energy is working on power generation through Supercritical Carbon dioxide and Hydrothermal Liquefaction since last 5 year. We have built up the first Hydro thermal liquefaction proto type plant in India.
Nabros Energy is actively working in chemical extraction field since last eighteen years. After successfully doing chemical extraction we have started to work on research and development in the field of Super Critical Carbon Dioxide Extraction. We have also working to develop Isothermal compressor to increase the overall plant efficiency and reduce the energy consumption.